Oceania & ASEAN Respiratory Market to Boost APAC Region Owing to Rising Chronic Respiratory Diseases - Asthma & COPD
May 05, 2015 at 22:00 PM EDT
SINGAPORE, LONDON and NEW YORK, May 6, 2015 /PRNewswire/ --
The only report on ASEAN respiratory devices with a detailed analysis of:
- Hospitals and retail channels
- Respiratory equipment-therapeutic, monitoring and diagnostic
- Markets such as Indonesia, Malaysia, Myanmar, Philippines, Singapore, Thailand and Vietnam as well as Australia, New Zealand and Bangladesh
The respiratory devices and diagnostics market comprises diagnostic devices such as spirometers and peak flow meters, monitoring devices like capnographs and pulse oximeters and therapeutic devices that include oxygen concentrators, nebulisers, Continuous Positive Airway Pressure (CPAP) devices, etc. The growth in ASEAN and Oceania respiratory devices and diagnostics market is anticipated to accelerate in coming years due to an increase in prevalence of chronic respiratory diseases like Chronic Obstructive Pulmonary Diseases (COPD), asthma and Obstructive Sleep Apnea (OSA) in both aging as well as young population in this region. ASEAN, Oceania and other APAC cover Australia, Bangladesh, Indonesia, Malaysia, Myanmar, New Zealand, Philippines, Singapore, Thailand and Vietnam.
The prevalence of respiratory diseases, especially asthma, is very high in the Oceania region and it is increasing in ASEAN countries due to growing smoking habit, air pollution, aging population, unhealthy diet and physical inactivity leading to COPD and OSA. "Due to the collective size of Indo-China market, ASEAN countries' potential is underestimated. ASEAN is expected to boost growth in the APAC region. For instance, Indonesia is highly populated with considerable cases of chronic respiratory diseases and low treatment penetration rates. We are expecting penetration to improve with government initiatives like mobile community health services and government-financed health coverage program," said Hansar Khan, senior analyst, ABMRG.
"Respiratory devices are divided in to two segments-Homecare devices and Hospital care devices. Though, Hospital is a leading segment, the demand for Homecare devices is increasing for all products in the Oceania region while the demand is surging for low-value products such as nebulisers and peak flow meters along with related disposables in the ASEAN region", said Nidhi Morkar, Asia Pacific analyst, ABMRG.
The demand for disposable consumables has increased over reusable ones due to safety concerns, a decline in prices of consumables, an increase in disposable income and improving diagnostics facilities.
A large number of players attracted to the low entry barrier high volume nature of the ASEAN market, has made the market highly fragmented and unorganised. Hospitals prefer economical devices if scrap life of the device is short and replacement is more economical than repair. Economical disposables are preferred in the case of patients who are provided home care due to cost benefits. Hospitals prefer local or Chinese disposables due to higher margins compared with products from multi-national companies (MNCs).
The key players in this market are AirSep Corporation, a division of Chart Industries, CareFusion Corp (NYSE : CFN), Covidien plc, DeVilbiss Healthcare LLC, Fisher & Paykel Healthcare Corp Ltd (NZE : FPH), Invacare Corporation, Omron Healthcare, Inc., a division of Omron Corporation (6645: TSE), Philips Respironics, Inc., a division of Koninklijke Philips N.V. (AMS : PHIA, NYSE : PHG), ResMed Inc (NYSE: RMD).
'ASEAN and Oceania Respiratory Devices and Diagnostics Market through 2020 - Detailed Analysis of Hospital and Retail market', a market report recently published by ABMRG, reviews historical trends and forecasts (between 2007 and 2020), annualised sales, market size (value and units), channel-wise revenue distribution for hospitals and retail, market growth, pricing, competitive landscape as well as overall and channel-wise market share.
It offers a proprietary cross-category comparison for products and geographies for the historical and forecast period. It also lists strategic developments in the global industry over the last two years, including M&As, partnerships, clinical studies, pipelines, product approvals and launches, recalls and litigations, market dynamics, market drivers and restraints.
Why one should buy this report
The report can be instrumental in formulating strategic decisions to:
Other strategic market reports by ABMRG:
ABMRG (Ace Business and Market Research Group) is a research and consulting firm focused on medical technology and pharmaceuticals. It offers comprehensive research and analytical studies targeting companies, therapeutic sectors and countries, highlighting market dynamics, vital trends, business strategies, clinical pipeline and technology advancements. Its cutting edge reports help companies make smarter, effective and faster strategic decisions for business growth.